Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.

Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.

Vaccine. 2018 Feb 14;36(8):1078-1084. doi: 10.1016/j.vaccine.2018.01.026. Epub 2018 Jan 20.

2.

Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.

Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ.

Vet Microbiol. 2017 May;203:196-201. doi: 10.1016/j.vetmic.2017.03.019. Epub 2017 Mar 18.

PMID:
28619144
3.

Interaction between FMDV Lpro and transcription factor ADNP is required for optimal viral replication.

Medina GN, Knudsen GM, Greninger AL, Kloc A, Díaz-San Segundo F, Rieder E, Grubman MJ, DeRisi JL, de Los Santos T.

Virology. 2017 May;505:12-22. doi: 10.1016/j.virol.2017.02.010. Epub 2017 Feb 17.

4.

Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.

Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T.

Virology. 2017 Feb;502:123-132. doi: 10.1016/j.virol.2016.12.021. Epub 2016 Dec 28.

5.

The activation of the IFNβ induction/signaling pathway in porcine alveolar macrophages by porcine reproductive and respiratory syndrome virus is variable.

Overend CC, Cui J, Grubman MJ, Garmendia AE.

Vet Res Commun. 2017 Mar;41(1):15-22. doi: 10.1007/s11259-016-9665-6. Epub 2016 Nov 28.

PMID:
27896670
6.

Combination of Adt-O1Manisa and Ad5-boIFNλ3 induces early protective immunity against foot-and-mouth disease in cattle.

Diaz-San Segundo F, Montiel NA, Sturza DF, Perez-Martin E, Hickman D, Ramirez-Medina E, Grubman MJ, de Los Santos T.

Virology. 2016 Dec;499:340-349. doi: 10.1016/j.virol.2016.09.027. Epub 2016 Oct 12.

7.

Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.

Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.

Vaccine. 2016 Jun 8;34(27):3214-3220. doi: 10.1016/j.vaccine.2015.12.018. Epub 2015 Dec 18.

8.

Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.

Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.

Clin Vaccine Immunol. 2015 Nov 25;23(2):125-36. doi: 10.1128/CVI.00426-15.

9.

Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.

Diaz-San Segundo F, Medina GN, Ramirez-Medina E, Velazquez-Salinas L, Koster M, Grubman MJ, de los Santos T.

J Virol. 2015 Nov 18;90(3):1298-310. doi: 10.1128/JVI.02167-15. Print 2016 Feb 1.

10.

A colorimetric bioassay for high-throughput and cost-effectively assessing anti-foot-and-mouth disease virus activity.

Ramanathan P, Zhu JJ, Bishop EA, Puckette MC, Hartwig E, Grubman MJ, Rodriguez LL.

Vet Immunol Immunopathol. 2015 Mar 15;164(1-2):74-8. doi: 10.1016/j.vetimm.2015.01.005. Epub 2015 Jan 22.

PMID:
25669593
11.

Poly ICLC increases the potency of a replication-defective human adenovirus vectored foot-and-mouth disease vaccine.

Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Salazar AM, Grubman MJ, de Los Santos T.

Virology. 2014 Nov;468-470:283-292. doi: 10.1016/j.virol.2014.08.012. Epub 2014 Sep 12.

12.

Type III interferon protects swine against foot-and-mouth disease.

Perez-Martin E, Diaz-San Segundo F, Weiss M, Sturza DF, Dias CC, Ramirez-Medina E, Grubman MJ, de los Santos T.

J Interferon Cytokine Res. 2014 Oct;34(10):810-21. doi: 10.1089/jir.2013.0112. Epub 2014 Apr 30.

PMID:
24786495
13.

Foot-and-mouth disease: technical and political challenges to eradication.

Smith MT, Bennett AM, Grubman MJ, Bundy BC.

Vaccine. 2014 Jun 30;32(31):3902-8. doi: 10.1016/j.vaccine.2014.04.038. Epub 2014 Apr 28. Review.

PMID:
24785105
14.

Characterization of cytotoxic T lymphocyte function after foot-and-mouth disease virus infection and vaccination.

Patch JR, Kenney M, Pacheco JM, Grubman MJ, Golde WT.

Viral Immunol. 2013 Aug;26(4):239-49. doi: 10.1089/vim.2013.0011. Epub 2013 Jul 5.

15.

An adenovirus vectored mucosal adjuvant augments protection of mice immunized intranasally with an adenovirus-vectored foot-and-mouth disease virus subunit vaccine.

Alejo DM, Moraes MP, Liao X, Dias CC, Tulman ER, Diaz-San Segundo F, Rood D, Grubman MJ, Silbart LK.

Vaccine. 2013 Apr 26;31(18):2302-9. doi: 10.1016/j.vaccine.2013.02.060. Epub 2013 Mar 13.

PMID:
23499593
16.

Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.

Diaz-San Segundo F, Dias CC, Moraes MP, Weiss M, Perez-Martin E, Owens G, Custer M, Kamrud K, de los Santos T, Grubman MJ.

J Virol. 2013 May;87(10):5447-60. doi: 10.1128/JVI.03462-12. Epub 2013 Mar 6.

17.

Novel antiviral therapeutics to control foot-and-mouth disease.

Dias CC, Moraes MP, Weiss M, Diaz-San Segundo F, Perez-Martin E, Salazar AM, de los Santos T, Grubman MJ.

J Interferon Cytokine Res. 2012 Oct;32(10):462-73. doi: 10.1089/jir.2012.0012. Epub 2012 Aug 27.

PMID:
22924938
18.

The presence of alpha interferon at the time of infection alters the innate and adaptive immune responses to porcine reproductive and respiratory syndrome virus.

Brockmeier SL, Loving CL, Nelson EA, Miller LC, Nicholson TL, Register KB, Grubman MJ, Brough DE, Kehrli ME Jr.

Clin Vaccine Immunol. 2012 Apr;19(4):508-14. doi: 10.1128/CVI.05490-11. Epub 2012 Feb 1.

19.

Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.

Perez-Martin E, Weiss M, Diaz-San Segundo F, Pacheco JM, Arzt J, Grubman MJ, de los Santos T.

J Virol. 2012 Apr;86(8):4477-87. doi: 10.1128/JVI.06683-11. Epub 2012 Feb 1.

20.

Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease.

Segundo FD, Weiss M, Pérez-Martín E, Dias CC, Grubman MJ, Santos Tde L.

J Virol. 2012 Feb;86(3):1316-27. doi: 10.1128/JVI.05941-11. Epub 2011 Nov 23.

21.

Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.

Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.

Vaccine. 2011 Nov 28;29(51):9431-40. doi: 10.1016/j.vaccine.2011.10.037. Epub 2011 Oct 24.

PMID:
22027486
22.

The pathogenesis of foot-and-mouth disease II: viral pathways in swine, small ruminants, and wildlife; myotropism, chronic syndromes, and molecular virus-host interactions.

Arzt J, Baxt B, Grubman MJ, Jackson T, Juleff N, Rhyan J, Rieder E, Waters R, Rodriguez LL.

Transbound Emerg Dis. 2011 Aug;58(4):305-26. doi: 10.1111/j.1865-1682.2011.01236.x. Epub 2011 Jun 15. Review.

PMID:
21672184
23.

Evidence of activation and suppression during the early immune response to foot-and-mouth disease virus.

Golde WT, de Los Santos T, Robinson L, Grubman MJ, Sevilla N, Summerfield A, Charleston B.

Transbound Emerg Dis. 2011 Aug;58(4):283-90. doi: 10.1111/j.1865-1682.2011.01223.x. Epub 2011 Apr 18. Review.

PMID:
21501424
24.

Antiviral activity of bovine type III interferon against foot-and-mouth disease virus.

Díaz-San Segundo F, Weiss M, Perez-Martín E, Koster MJ, Zhu J, Grubman MJ, de los Santos T.

Virology. 2011 May 10;413(2):283-92. doi: 10.1016/j.virol.2011.02.023. Epub 2011 Mar 24.

25.

Induction of foot-and-mouth disease virus-specific cytotoxic T cell killing by vaccination.

Patch JR, Pedersen LE, Toka FN, Moraes M, Grubman MJ, Nielsen M, Jungersen G, Buus S, Golde WT.

Clin Vaccine Immunol. 2011 Feb;18(2):280-8. doi: 10.1128/CVI.00417-10. Epub 2010 Dec 22.

26.

Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus.

Dias CC, Moraes MP, Segundo FD, de los Santos T, Grubman MJ.

J Interferon Cytokine Res. 2011 Feb;31(2):227-36. doi: 10.1089/jir.2010.0055. Epub 2010 Sep 28.

PMID:
20874428
27.

Marked differences between MARC-145 cells and swine alveolar macrophages in IFNβ-induced activation of antiviral state against PRRSV.

He D, Overend C, Ambrogio J, Maganti RJ, Grubman MJ, Garmendia AE.

Vet Immunol Immunopathol. 2011 Jan;139(1):57-60. doi: 10.1016/j.vetimm.2010.07.023. Epub 2010 Aug 7.

PMID:
20832126
28.

Differential gene expression in bovine cells infected with wild type and leaderless foot-and-mouth disease virus.

Zhu J, Weiss M, Grubman MJ, de los Santos T.

Virology. 2010 Aug 15;404(1):32-40. doi: 10.1016/j.virol.2010.04.021. Epub 2010 May 23.

29.

Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.

Diaz-San Segundo F, Moraes MP, de Los Santos T, Dias CC, Grubman MJ.

J Virol. 2010 Feb;84(4):2063-77. doi: 10.1128/JVI.01874-09. Epub 2009 Dec 2.

30.

Foot and mouth disease virus vaccines.

Rodriguez LL, Grubman MJ.

Vaccine. 2009 Nov 5;27 Suppl 4:D90-4. doi: 10.1016/j.vaccine.2009.08.039. Review.

PMID:
19837296
31.

Adenovirus-mediated expression of interferon-alpha delays viral replication and reduces disease signs in swine challenged with porcine reproductive and respiratory syndrome virus.

Brockmeier SL, Lager KM, Grubman MJ, Brough DE, Ettyreddy D, Sacco RE, Gauger PC, Loving CL, Vorwald AC, Kehrli ME Jr, Lehmkuhl HD.

Viral Immunol. 2009 Jun;22(3):173-80. doi: 10.1089/vim.2008.0075.

PMID:
19435413
32.

A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.

de los Santos T, Segundo FD, Zhu J, Koster M, Dias CC, Grubman MJ.

J Virol. 2009 Feb;83(4):1800-10. doi: 10.1128/JVI.02112-08. Epub 2008 Dec 3.

33.

Deceptive imprinting and immune refocusing in vaccine design.

Tobin GJ, Trujillo JD, Bushnell RV, Lin G, Chaudhuri AR, Long J, Barrera J, Pena L, Grubman MJ, Nara PL.

Vaccine. 2008 Nov 18;26(49):6189-99. doi: 10.1016/j.vaccine.2008.09.080. Epub 2008 Oct 11.

PMID:
18852005
34.

Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.

Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, Grubman MJ.

Vaccine. 2008 Oct 23;26(45):5689-99. doi: 10.1016/j.vaccine.2008.08.022. Epub 2008 Aug 30.

PMID:
18762225
35.

Evading the host immune response: how foot-and-mouth disease virus has become an effective pathogen.

Grubman MJ, Moraes MP, Diaz-San Segundo F, Pena L, de los Santos T.

FEMS Immunol Med Microbiol. 2008 Jun;53(1):8-17. doi: 10.1111/j.1574-695X.2008.00409.x. Epub 2008 Apr 8. Review.

36.

Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection.

de Los Santos T, Diaz-San Segundo F, Grubman MJ.

J Virol. 2007 Dec;81(23):12803-15. Epub 2007 Sep 19.

37.

Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.

Moraes MP, de Los Santos T, Koster M, Turecek T, Wang H, Andreyev VG, Grubman MJ.

J Virol. 2007 Jul;81(13):7124-35. Epub 2007 Apr 25.

38.

Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with Porcine reproductive and respiratory syndrome virus.

Overend C, Mitchell R, He D, Rompato G, Grubman MJ, Garmendia AE.

J Gen Virol. 2007 Mar;88(Pt 3):925-31.

PMID:
17325366
39.

Immunopotentiation of a foot-and-mouth disease virus subunit vaccine by interferon alpha.

de Avila Botton S, Brum MC, Bautista E, Koster M, Weiblen R, Golde WT, Grubman MJ.

Vaccine. 2006 Apr 24;24(17):3446-56. Epub 2006 Feb 20.

PMID:
16522345
40.
41.

Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.

Grubman MJ.

Biologicals. 2005 Dec;33(4):227-34. Epub 2005 Nov 14.

PMID:
16289996
44.

Constitutive expression of alpha interferon by skin dendritic cells confers resistance to infection by foot-and-mouth disease virus.

Bautista EM, Ferman GS, Gregg D, Brum MC, Grubman MJ, Golde WT.

J Virol. 2005 Apr;79(8):4838-47.

45.

Rapid control of foot-and-mouth disease outbreaks: is RNAi a possible solution?

Grubman MJ, de los Santos T.

Trends Immunol. 2005 Feb;26(2):65-8. No abstract available.

PMID:
15668119
46.

New approaches to rapidly control foot-and-mouth disease outbreaks.

Grubman MJ.

Expert Rev Anti Infect Ther. 2003 Dec;1(4):579-86. Review.

PMID:
15482155
47.

Foot-and-mouth disease.

Grubman MJ, Baxt B.

Clin Microbiol Rev. 2004 Apr;17(2):465-93. Review.

48.

Engineering better vaccines for foot-and-mouth disease.

Mason PW, Chinsangaram J, Moraes MP, Mayr GA, Grubman MJ.

Dev Biol (Basel). 2003;114:79-88.

PMID:
14677679
50.

Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.

Wu Q, Brum MC, Caron L, Koster M, Grubman MJ.

J Interferon Cytokine Res. 2003 Jul;23(7):359-68.

PMID:
14511462

Supplemental Content

Loading ...
Support Center